Co-expression of Erns and E2 genes of classical swine fever virus by replication-defective recombinant adenovirus completely protects pigs against virulent challenge with classical swine fever virus.

作者: Yongke Sun , Yuai Yang , Huanli Zheng , Dongmei Xi , Mingxing Lin

DOI: 10.1016/J.RVSC.2012.09.012

关键词:

摘要: The objective of this study was to construct a recombinant adenovirus for future CSFV vaccines used in the pig industry reduction losses involved CSF outbreaks. Erns and E2 genes classical swine fever virus (CSFV), which encode two main protective glycoproteins from "Shimen" strain CSFV, were combined inserted into replication-defective human type-5 named rAd-Erns-E2. Nine pigs randomly assigned three treatment groups (three each group) including rAd-Erns-E2, hAd-CMV control DMEM control. Intramuscular vaccination with 2×10(6) TCID(50) rAd-Erns-E2 administered times an interval 21 days. At 42 days post inoculation, all challenged lethal dose 1×10(3) strain. Observation clinical signs made existence RNA detected. Animals showed severe symptoms euthanized 7 10 after challenge. However, no adverse observed vaccinated administration even Neither nor pathological changes detected tissues interest above pigs. These results implied that recombination carrying Erns-E2 could be prevent fever.

参考文章(37)
C. Terpstra, R. Woortmeyer, S. J. Barteling, Development and properties of a cell culture produced vaccine for hog cholera based on the Chinese strain. Deutsche Tierarztliche Wochenschrift. ,vol. 97, pp. 77- 79 ,(1990)
Yung-Shyeng Tsao, Russell Condon, Eugene Schaefer, Peggy Lio, Zhong Liu, Development and improvement of a serum-free suspension process for the production of recombinant adenoviral vectors using HEK293 cells. Cytotechnology. ,vol. 37, pp. 189- 198 ,(2001) , 10.1023/A:1020555310558
Gregor Meyers, Heinz-Jürgen Thiel, Molecular Characterization of Pestiviruses Advances in Virus Research. ,vol. 47, pp. 53- 118 ,(1996) , 10.1016/S0065-3527(08)60734-4
M.-L. Penrith, W. Vosloo, C. Mather, Classical Swine Fever (Hog Cholera): Review of Aspects Relevant to Control Transboundary and Emerging Diseases. ,vol. 58, pp. 187- 196 ,(2011) , 10.1111/J.1865-1682.2011.01205.X
Alicja Józkowicz, Józef Dulak, Helper-dependent adenoviral vectors in experimental gene therapy Acta Biochimica Polonica. ,vol. 52, pp. 589- 599 ,(2005) , 10.18388/ABP.2005_3419
T Christopher Mast, Lisa Kierstead, Swati B Gupta, Alexander A Nikas, Esper G Kallas, Vladimir Novitsky, Bernard Mbewe, Punee Pitisuttithum, Mauro Schechter, Eftyhia Vardas, Nathan D Wolfe, Miguel Aste-Amezaga, Danilo R Casimiro, Paul Coplan, Walter L Straus, John W Shiver, None, International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials Vaccine. ,vol. 28, pp. 950- 957 ,(2010) , 10.1016/J.VACCINE.2009.10.145
Erlinda Fernández, Jorge R. Toledo, Maylin Chiong, Francisco Parra, Elsa Rodríguez, Carlos Montero, Lídice Méndez, Lorenzo Capucci, Omar Farnós, Single dose adenovirus vectored vaccine induces a potent and long-lasting immune response against rabbit hemorrhagic disease virus after parenteral or mucosal administration. Veterinary Immunology and Immunopathology. ,vol. 142, pp. 179- 188 ,(2011) , 10.1016/J.VETIMM.2011.05.007